Opportunity Overview
Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Research Award (TrRA) supports non-incremental, robust, well-designed research that drives transformative advancements in reducing risk and preventing the development of Alzheimer’s disease and/or Alzheimer's disease related dementias (AD/ADRD).
Distinctive Features:
• Applications must address at least one of the following focus areas:
○ Risk Factor Knowledge: Research that advances understanding, identification, and/or validation of risk and/or protective factors, with research outcomes/products focused on accelerating solutions. Projects may include, but are not limited to, research on environmental, epigenetic, genetic, lifestyle, occupational, or other risks not listed here.
○ Risk Reduction Solutions: Research that describes methods, technologies, and strategies that contribute to reducing risk and preventing AD/ADRD.
• Clinical research is allowed, however clinical trials and animal research are prohibited.
• Preliminary data are required.
• Community collaboration is required for research prospectively enrolling human subjects.
• Career Initiation or Transition (CIT) Partnership Option: The TrRA includes an option for more than one PI and supports both new and existing collaborative partnerships. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). If utilizing this option, at least one independent investigator must meet
Distinctive Features:
• Applications must address at least one of the following focus areas:
○ Risk Factor Knowledge: Research that advances understanding, identification, and/or validation of risk and/or protective factors, with research outcomes/products focused on accelerating solutions. Projects may include, but are not limited to, research on environmental, epigenetic, genetic, lifestyle, occupational, or other risks not listed here.
○ Risk Reduction Solutions: Research that describes methods, technologies, and strategies that contribute to reducing risk and preventing AD/ADRD.
• Clinical research is allowed, however clinical trials and animal research are prohibited.
• Preliminary data are required.
• Community collaboration is required for research prospectively enrolling human subjects.
• Career Initiation or Transition (CIT) Partnership Option: The TrRA includes an option for more than one PI and supports both new and existing collaborative partnerships. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). If utilizing this option, at least one independent investigator must meet
Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | Defense Health Agency Contracting Activity - DHACA |
|---|---|
| Country | United States |
| Category | Research and Studies |
| Estimated value | $4.0M |
| Published | May 01, 2026 |
| Procurement stage | Active solicitation |
| Closed | September 24, 2026 |
| Status | Closed — no longer accepting responses |
| Official source | View original notice |
| Last verified | October 11, 2026 |
Source: U.S. Government (Simpler.Grants.gov) — public domain. Not affiliated with or endorsed by the United States Government.
United States market overview →Research and Studies tenders in United States →Browse all categories →
Browse Similar Open Opportunities in United States
See every United States Research and Studies opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free United States Research and Studies intelligence report in your inbox
A personalized report on United States Research and Studies opportunities, emailed in 5-10 minutes. One per month, no account needed.